Join Roche at ESC Congress 2025 in Madrid from August 29 to September 1, where science meets innovation in cardiovascular care. Visit us at Booth B430 to discover how we are transforming the cardiac care continuum — from early diagnosis to personalized treatment and long-term monitoring.
Delivering holistic care for people living with cardiometabolic conditions - from diagnosis to treatment to ongoing monitoring
As the leader in in vitro diagnostics, we discover and develop novel, high-quality, accurate assays, point-of-care devices, and digital solutions to deliver on unmet medical needs. Our goal is to enable excellence in patient-centric decision-making and help tackle the high burden of Cardiometabolic diseases in our society.
What to Expect at Our Booth
Join us at our upcoming event where you can explore the forefront of medical innovation. Our booth is designed to provide you with an immersive experience, featuring:
The Medical Corner: Advancing CVRM Drug Development
Step into our Medical Corner to explore how Roche is contributing to the future of CVRM treatment through data-driven research and collaborative innovation.
Clinical Dialogue with Leaders
Engage in direct conversations with Roche scientists and clinical experts. Learn about our latest breakthroughs, ask your questions, and exchange perspectives on improving cardiometabolic care.
Product Showcases – Explore What’s New
- Elecsys® Troponin T hs Gen 6* – Upcoming Launch! Discover our next-generation high-sensitivity Troponin T assay, designed to optimize the diagnostic process of myocardial infarction and support confident clinical decision-making.
- LumiraDx: See our newest point-of-care system in action, the cutting-edge, portable diagnostic solution designed to radically simplify diagnostics and reshape the healthcare journey for patients and professionals at the Point of Need.
- Lp(a) Assay: Learn about the role of Lp(a) in residual cardiovascular risk - and how our assay enables better risk stratification.
Beyond these highlights, you'll find a wealth of other valuable information and resources.
*product is in development and not yet commercially available.
